SnooZeal, the clever phone controlled anti-snoring/sleep apnoea wearable tech device prevents the risk of serious health problems caused by snoring

SnooZeal, is the world's first over the counter smart phone controlled anti-snoring/sleep apnoea device aimed at reversing the root cause of snoring and obstructive sleep apnoea during sleep. The app, used in conjunction with the device, works like a Fit Bit for snoring, keeping users on track and able to monitor improvement daily. In a crowded and fast-growing $33bn anti-snoring/sleep apnoea market, there are no other products like this available.

Not only can snoring seriously disrupt sleep patterns of the snorer and their partner, it is often the precursor to Sleep Apnoea. If untreated sleep apnoea can cause high blood pressure and put people at risk from stroke, recurrent heart attacks and abnormal heart beats.

Unlike all other anti-snoring/sleep apnoea devices that only relieve not treat snoring currently available, SnooZeal is only used for 20 minutes a day and not worn at night. In a market that is worth $33bn a year and predicted to rise to $77bn by 2020, SnooZeal takes anti snoring/sleep apnoea wearable tech to the next level. This cleverly controlled by a phone app, Snoozeal's users monitor their progress and treatment via the app to help them treat the physiological cause of snoring and sleep apnoea.

Even though Sleep Apnoea is a serious health problem patients often stop wearing their night time sleep apparatus because they find it claustrophobic and uncomfortable, putting them at risk from serious health problems caused by OSA. Because SnooZeal is only worn for 20 minutes during the day there is no need to wear cumbersome equipment at night which interferes with your sleep bring a safer night sleep to those at risk.

Developed by a renowned ENT consultant Professor Anshul Sama, SnooZeal addresses the root cause of excessive relaxation and loss of tongue muscle tone during sleep, which obstructs the breathing passage and leads to snoring and sleep apnoea. Effectively giving the tongue a "work-out" SnooZeal's novel technology sends gentle electronic pulses to the back of the tongue to tone the muscles which reverses the over-relaxation of the tongue and stops snoring.

The three-part SnooZeal device is used during the day only and is worn for just 20-25 minutes, twice a day over a 6-week period. It uses wireless technology and there is a smart phone app to control the progress of the treatment.

"In the US alone, over 90m Americans snore every night, not only disturbing their sleep but that of their partners too. Noisy snoring strains relationships as it disrupts the partners sleep more than the snorers. It is well known that the long-term effects of sleep deprivation and disturbed sleep can lead to serious health problems", says Professor Sama, Senior Consultant Surgeon at Nottingham University.

SnooZeal is also seeking early round funding as interest grows from major retailers and potential distribution partners in the USA in advance of FDA approval. Results from the first set of clinical trials are due to be published in Q1.

Hemavli Bali, M&A advisor at Deloitte specialising in healthcare technology and life science transactions.

"The sleep market is a hugely attractive one for med tech innovation, BCC research estimated in 2014 that the sleep market would be worth $77bn by 2019. As the consumerism of healthcare and focus on wellness rises there is increasing public awareness of the knock-on effects on health and cognitive function from poor quality and duration of sleep. The timing is ideal to attract significant interest from both the public and clinicians in new, improved medical devices which utilise modern technological advancement to address sleep apnoea and snoring. Those products which go further to cure the causes of snoring and sleep disorders rather than simply addressing the symptoms are likely to emerge as clear winners in this market, particularly those that are non-invasive, user friendly and available over the counter".

The SnooZeal team includes medical and engineering experts that include Professor Boris Stuck, Professor Russell Harris, Mr Jason Watson and Tom Tucker an entrepreneur who has successfully launched over 200 medical equipment products. SnooZeal has got initial projected sales of 400,000 units in the US alone and the company is currently looking for strategic partners as a second set of trials is due to commence in Q1 at UCLH, one of the UK's top teaching hospitals.

Since receiving CE approval earlier this month the team behind SnooZeal are working on European pre-sales with retailers, ENT Consultants, medical device distributors and sleep physicians. SnooZeal has a patent granted and has retained ISO13485, FDA approval is expected soon as trial results are equally awaited.

"Many night time anti-snoring/sleep apnoea devices are often abandoned as people find them uncomfortable and ineffective. What makes SnooZeal so innovative and effective is that it addresses the root cause of snoring rather than just temporally relieving it, and because SnooZeal is only used during the day, it means that users can sleep naturally at night", says Professor Sama.

Ends

www.snoozeal.com

For further information please contact Caroline Ratner, caroline.ratner@snoozeal.com +4420 8209 0120, +7976 765453 caroline@carolinecomms.com

Notes to Editors

Watch the video http://www.snoozeal.com/